Banner Location Image
Request Free Consultation
Posted on June 25, 2013

FDA Issues New Warning About Hydroxyethyl Starch Solutions

Data recently brought to light has led the Food and Drug Administration to issue a warning about Hydroxyethyl Starch Solutions.  The product, which is designed to increase plasma in persons suffering from hypovolemia, could reportedly create adverse circumstances if the recipient is an adult who is critically ill.  Specifically, such persons could sustain renal impairment… read more

Read Article
Posted on May 29, 2013

Antihistamine Usage Could Have Consequences For Road Safety

Have you noticed an increase in the number of people with red eyes sneezing and constantly wiping their noses?  As people who suffer from severe allergies can attest, allergy season is in full effect, and those who experience reactions to pet dander, pollen in the air, and anything else will reach for an antihistamine in… read more

Read Article
Posted on May 16, 2013

Sunscreen Safety Tips Offered By FDA Ahead Of Don’t Fry Day

In December of last year, new regulations from the Food and Drug Administration regarding sunscreens came into effect.  No longer can a product make claims that it’s waterproof or that it can last for more than two hours without additional application.  And if a sunscreen doesn’t protect users from both UVA and UVB rays (known… read more

Read Article
Posted on May 10, 2013

FDA Warns Pregnant Women To Take Precautions With Medication

A news release finds the Food and Drug Administration warning pregnant women to take the proper precautions when it comes to medication.  The agency explains that drugs that might be alright to take pre-pregnancy could prove to be dangerous to either you or your unborn child during a pregnancy. Instead of taking to the wilds… read more

Read Article
Posted on May 1, 2013

FDA Warns Users Not to Take Samsca For Extended Periods

The Food and Drug Administration has issued a communication warning consumers about the deleterious side effects that could be presented if they take Samsca for too long.  The drug, which is typically taken by those suffering from euvolemic and hypervolemic hyponatremia, will receive a new label detailing the potential threat posed when a user takes… read more

Read Article
Posted on April 29, 2013

FDA Warns of Discoloration Risk Associated With Potiga

The Food and Drug Administration has issued a report focused on a startling side effect that can occur when a patient takes Potiga, an anti-seizure drug.  Meant to be used by adults, the medication apparently has the potential to turn an individual’s skin a blue hue.  This tends to occur in the fingernails and lips… read more

Read Article
Posted on April 12, 2013

Risks of DMAA Detailed By The FDA

Spurred on by a wave of reports alleging injurious circumstances in conjunction with a substance known as DMAA (or dimethylamylamine), the Food and Drug Administration has issued a warning to consumers about the stimulant.  They’re also attempting to use this particular incident as a means to explain the difficulties of overseeing the safety of dietary… read more

Read Article
Posted on March 19, 2013

FDA Warns Azithromycin Users of Irregular Heart Rhythm Risk

The Food and Drug Administration is warning doctors and patients of the recently discovered increased risk of irregular heart rhythm that could confront users of azithromycin.  Known more commonly as Zmax or Zithromax, two studies recently turned up an issue wherein the heart’s electrical activity could experience abnormality leading to the aforementioned rhythm issue, which… read more

Read Article
Posted on March 18, 2013

FDA Attempts to Protect Sensitive Individuals From Latex Dangers

Latex allergies are far more prevalent than many people might realize.  In fact, the Occupational Health and Safety Administration figures that as much as 6% of the population is allergic to latex.  This number actually increases when looking at the healthcare industry, where up to 12% of people could have a sensitivity to the substance…. read more

Read Article
Posted on March 15, 2013

Incivek Hepatitis C Treatment Receives More Severe Warning Label

The Food and Drug Administration has grown concerned that patients aren’t taken warnings about a certain Hepatitis C treatment seriously enough.  Because of that, they have issued a more severe warning about the issue which has already led some patients to experience fatal side effects. The drug in question is known as Incivek, a Hepatitis… read more

Read Article
Posted on March 4, 2013

FDA Explains How to Spot Fraudulent Drugs

If a drug claim sounds too good to be true, chances are that it is too good to be true.  The rise of the internet, email, and social media has ushered in rampant marketing of fraudulent medications that have not received the approval of the Food and Drug Administration, and many consumers get taken in… read more

Read Article
Posted on February 25, 2013

FDA Warns Of Omontys Injection Health Risks; Recall Issued

The Food and Drug Administration is warning consumers and healthcare professionals of the dangers posed by a drug meant to treat anemia in those adult persons going through dialysis.  If you fall into this category, then it’s imperative that you read on to learn more about the hazard posed by the drug. The recall being… read more

Read Article

How Can We Help You?

If you have a legal matter you would like to discuss with an attorney from our firm, please call us at (310) 477-1700 or complete and submit the e-mail form below, and we will get back to you.

  • This field is for validation purposes and should be left unchanged.
  • This field is for validation purposes and should be left unchanged.

*Required Fields